February 12, 2025
Sell AstraZeneca, says UBS, which upgrades European rivals including GSK

UBS analysts shook up their ratings of European drugmakers, including making a double-downgrade of AstraZeneca and a double-upgrade of U.K. rival GSK…
Read More

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *